169 related articles for article (PubMed ID: 18767022)
1. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry.
Xue R; Lin Z; Deng C; Dong L; Liu T; Wang J; Shen X
Rapid Commun Mass Spectrom; 2008 Oct; 22(19):3061-8. PubMed ID: 18767022
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
[TBL] [Abstract][Full Text] [Related]
3. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
4. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
[TBL] [Abstract][Full Text] [Related]
6. Analysis of mass spectral serum profiles for biomarker selection.
Ressom HW; Varghese RS; Abdel-Hamid M; Eissa SA; Saha D; Goldman L; Petricoin EF; Conrads TP; Veenstra TD; Loffredo CA; Goldman R
Bioinformatics; 2005 Nov; 21(21):4039-45. PubMed ID: 16159919
[TBL] [Abstract][Full Text] [Related]
7. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
8. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
[TBL] [Abstract][Full Text] [Related]
9. Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis.
Nahon P; Amathieu R; Triba MN; Bouchemal N; Nault JC; Ziol M; Seror O; Dhonneur G; Trinchet JC; Beaugrand M; Le Moyec L
Clin Cancer Res; 2012 Dec; 18(24):6714-22. PubMed ID: 23136190
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue.
Mal M; Koh PK; Cheah PY; Chan EC
Rapid Commun Mass Spectrom; 2009 Feb; 23(4):487-94. PubMed ID: 19140133
[TBL] [Abstract][Full Text] [Related]
11. [Discriminant function based on serum analyte for diagnosis of primary hepatic cancer].
Yi B; Luo JQ; Tang Y; Huang YD
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):373-5. PubMed ID: 12206007
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma.
Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Ono K; Kubo S
J Hepatobiliary Pancreat Surg; 2006; 13(3):239-44. PubMed ID: 16708302
[TBL] [Abstract][Full Text] [Related]
13. Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma.
Zhang X; Thiéfin G; Gobinet C; Untereiner V; Taleb I; Bernard-Chabert B; Heurgué A; Truntzer C; Ducoroy P; Hillon P; Sockalingum GD
Transl Res; 2013 Nov; 162(5):279-86. PubMed ID: 23920432
[TBL] [Abstract][Full Text] [Related]
14. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
[TBL] [Abstract][Full Text] [Related]
15. Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma.
Bachtiar I; Santoso JM; Atmanegara B; Gani RA; Hasan I; Lesmana LA; Sulaiman A; Gu J; Tai S
Clin Chim Acta; 2009 Jan; 399(1-2):97-101. PubMed ID: 18926809
[TBL] [Abstract][Full Text] [Related]
16. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
Luk JM; Lam BY; Lee NP; Ho DW; Sham PC; Chen L; Peng J; Leng X; Day PJ; Fan ST
Biochem Biophys Res Commun; 2007 Sep; 361(1):68-73. PubMed ID: 17644064
[TBL] [Abstract][Full Text] [Related]
17. [Screening of serum biomarkers in hepatocellular carcinoma by SELDI technique: a preliminary study].
Yao DK; Zhu L; Wang WJ; Song ST
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):298-9. PubMed ID: 17456321
[No Abstract] [Full Text] [Related]
18. A concise review of serum markers for hepatocellular cancer.
Wright LM; Kreikemeier JT; Fimmel CJ
Cancer Detect Prev; 2007; 31(1):35-44. PubMed ID: 17293059
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of hepatocellular carcinoma in cirrhotic patients: a proof-of-concept study using serum micro-Raman spectroscopy.
Taleb I; Thiéfin G; Gobinet C; Untereiner V; Bernard-Chabert B; Heurgué A; Truntzer C; Hillon P; Manfait M; Ducoroy P; Sockalingum GD
Analyst; 2013 Jul; 138(14):4006-14. PubMed ID: 23608738
[TBL] [Abstract][Full Text] [Related]
20. Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats.
Lu Y; A J; Wang G; Hao H; Huang Q; Yan B; Zha W; Gu S; Ren H; Zhang Y; Fan X; Zhang M; Hao K
Rapid Commun Mass Spectrom; 2008 Sep; 22(18):2882-8. PubMed ID: 18720470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]